Abstract

PSY42 - The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PDG62 Outcomes of Benefit Reassessments of Medicinal Products in Germany after Expiry of the Limitation of G-BA Resolution
L Kleinesudeik ... M.P Schoenermark
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
L Kleinesudeik, et. al.L Kleinesudeik ... M.P Schoenermark
01 Dec 2020
PRO94 Outcomes of Benefit Reassessments of Orphan Drugs in Germany after Exceedance of the 50-Million-EURO Revenue Threshold
L Frick ... M.P Schoenermark
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
L Frick, et. al.L Frick ... M.P Schoenermark
01 Dec 2020
PCN176 - Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts
U Theidel ... T Mittendorf
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 17
U Theidel, et. al.U Theidel ... T Mittendorf
26 Oct 2014
PHP137 - REIMBURSEMENT OF ORPHAN DRUGS UNDER EARLY BENEFIT ASSESMENT IN GERMANY
T Ecker ... D Bot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 19
T Ecker, et. al.T Ecker ... D Bot
01 May 2016
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
View more papers